3-(2,2,2-trimethylhydrazine)propionate has been researched along with haloperidol in 1 studies
Studies (3-(2,2,2-trimethylhydrazine)propionate) | Trials (3-(2,2,2-trimethylhydrazine)propionate) | Recent Studies (post-2010) (3-(2,2,2-trimethylhydrazine)propionate) | Studies (haloperidol) | Trials (haloperidol) | Recent Studies (post-2010) (haloperidol) |
---|---|---|---|---|---|
251 | 35 | 105 | 20,330 | 1,753 | 3,294 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beitnere, U; Dzirkale, Z; Isajevs, S; Klusa, V; Rumaks, J; Svirskis, S | 1 |
1 other study(ies) available for 3-(2,2,2-trimethylhydrazine)propionate and haloperidol
Article | Year |
---|---|
Carnitine congener mildronate protects against stress- and haloperidol-induced impairment in memory and brain protein expression in rats.
Topics: Acetylcholinesterase; Animals; Avoidance Learning; Biomarkers; Brain; Brain-Derived Neurotrophic Factor; Carnitine; Glutamate Decarboxylase; GPI-Linked Proteins; Haloperidol; Male; Maze Learning; Memory; Methylhydrazines; Nerve Tissue Proteins; Neuroprotective Agents; Rats; Rats, Wistar; Stress, Physiological | 2014 |